FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

9044611000001103: Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
29893301000001115 Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65343801000001115 Gaviscon Advance Mint chewable tablets (Forum Health Products Ltd) 60 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Is a Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free 60 tablet true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Is pack of Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) false Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Has active ingredient Sodium alginate false Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Has active ingredient Potassium bicarbonate false Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Has excipient Aspartame false Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Legal category General sales list true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Has manufactured dose form Conventional release chewable tablet false Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Has AMP Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Has specific active ingredient Sodium alginate true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Has specific active ingredient Potassium bicarbonate true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Has dispensed dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Flavour Mint true Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Gaviscon Advance chewable tablets (Reckitt Benckiser Plc) 60 tablet 3 x 20 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start